Shandong Sinobioway Biomedicine (SHE:002581), through unit Shandong Yandu Biotechnology, signed a 54 million yuan purchase deal to buy materials for its human nerve growth factor eye drops, according to a Shenzhen Stock Exchange disclosure on Wednesday.
Under the deal, Yandu Biotechnology will purchase storage liquid and chromatography systems, fillers, and reaction bags from Jiangsu Suhao Innovation Technology Group, the Chinese pharmaceutical company said.
The amount included nearly 14 million yuan for the fillers and reaction bags and around 40 million yuan for the storage liquid and chromatography systems.